[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Irritable Bowel Syndrome (IBS) Market Analysis 2016-2020 and Forecast 2021-2026

March 2021 | 89 pages | ID: G48F11C6F74FEN
99Strategy

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SNAPSHOT

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
The global Irritable Bowel Syndrome (IBS) market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Irritable Bowel Syndrome (IBS) by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
  • IBS-D Drug
  • IBS-C Drug
  • Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
  • Valeant Pharmaceuticals
  • Allergan
  • Takeda
  • Sucampo Pharmaceuticals
  • McNeil Consumer Healthcare
  • Sebela Pharmaceuticals
  • Astellas Pharmaceuticals
  • IM HealthScience
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
  • Women
  • Men
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
  • Asia-Pacific (China, India, Japan, Southeast Asia etc.)
  • South America (Brazil, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, South Africa etc.)
1 INDUSTRY OVERVIEW

1.1 Irritable Bowel Syndrome (IBS) Industry
Figure Irritable Bowel Syndrome (IBS) Industry Chain Structure
  1.1.1 Overview
  1.1.2 Development of Irritable Bowel Syndrome (IBS)
1.2 Market Segment
  1.2.1 Upstream
Table Upstream Segment of Irritable Bowel Syndrome (IBS)
  1.2.2 Downstream
Table Application Segment of Irritable Bowel Syndrome (IBS)
Table Global Irritable Bowel Syndrome (IBS) Market 2016-2026, by Application, in USD Million
  1.2.3 COVID-19 Impact
1.3 Cost Analysis

2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)

2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

3 IRRITABLE BOWEL SYNDROME (IBS) MARKET BY TYPE

3.1 By Type
  3.1.1 IBS-D Drug
Table Major Company List of IBS-D Drug
  3.1.2 IBS-C Drug
Table Major Company List of IBS-C Drug
  3.1.3 Others
Table Major Company List of Others
3.2 Market Size
Table Global Irritable Bowel Syndrome (IBS) Market 2016-2020, by Type, in USD Million
Figure Global Irritable Bowel Syndrome (IBS) Market Growth 2016-2020, by Type, in USD Million
Table Global Irritable Bowel Syndrome (IBS) Market 2016-2020, by Type, in Volume
Figure Global Irritable Bowel Syndrome (IBS) Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Irritable Bowel Syndrome (IBS) Market Forecast 2021-2026, by Type, in USD Million
Table Global Irritable Bowel Syndrome (IBS) Market Forecast 2021-2026, by Type, in Volume

4 MAJOR COMPANIES LIST

4.1 Valeant Pharmaceuticals (Company Profile, Sales Data etc.)
  4.1.1 Valeant Pharmaceuticals Profile
Table Valeant Pharmaceuticals Overview List
  4.1.2 Valeant Pharmaceuticals Products & Services
  4.1.3 Valeant Pharmaceuticals Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Allergan (Company Profile, Sales Data etc.)
  4.2.1 Allergan Profile
Table Allergan Overview List
  4.2.2 Allergan Products & Services
  4.2.3 Allergan Business Operation Conditions
Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Takeda (Company Profile, Sales Data etc.)
  4.3.1 Takeda Profile
Table Takeda Overview List
  4.3.2 Takeda Products & Services
  4.3.3 Takeda Business Operation Conditions
Table Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Sucampo Pharmaceuticals (Company Profile, Sales Data etc.)
  4.4.1 Sucampo Pharmaceuticals Profile
Table Sucampo Pharmaceuticals Overview List
  4.4.2 Sucampo Pharmaceuticals Products & Services
  4.4.3 Sucampo Pharmaceuticals Business Operation Conditions
Table Business Operation of Sucampo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 McNeil Consumer Healthcare (Company Profile, Sales Data etc.)
  4.5.1 McNeil Consumer Healthcare Profile
Table McNeil Consumer Healthcare Overview List
  4.5.2 McNeil Consumer Healthcare Products & Services
  4.5.3 McNeil Consumer Healthcare Business Operation Conditions
Table Business Operation of McNeil Consumer Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Sebela Pharmaceuticals (Company Profile, Sales Data etc.)
  4.6.1 Sebela Pharmaceuticals Profile
Table Sebela Pharmaceuticals Overview List
  4.6.2 Sebela Pharmaceuticals Products & Services
  4.6.3 Sebela Pharmaceuticals Business Operation Conditions
Table Business Operation of Sebela Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Astellas Pharmaceuticals (Company Profile, Sales Data etc.)
  4.7.1 Astellas Pharmaceuticals Profile
Table Astellas Pharmaceuticals Overview List
  4.7.2 Astellas Pharmaceuticals Products & Services
  4.7.3 Astellas Pharmaceuticals Business Operation Conditions
Table Business Operation of Astellas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 IM HealthScience (Company Profile, Sales Data etc.)
  4.8.1 IM HealthScience Profile
Table IM HealthScience Overview List
  4.8.2 IM HealthScience Products & Services
  4.8.3 IM HealthScience Business Operation Conditions
Table Business Operation of IM HealthScience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

5 MARKET COMPETITION

5.1 Company Competition
Table Global Irritable Bowel Syndrome (IBS) Sales Revenue 2016-2020, by Company, in USD Million
Table Global Irritable Bowel Syndrome (IBS) Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Irritable Bowel Syndrome (IBS) Sales Revenue Share in 2020, by Company, in USD Million
Table Global Irritable Bowel Syndrome (IBS) Sales Volume 2016-2020, by Company, in Volume
Table Global Irritable Bowel Syndrome (IBS) Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Irritable Bowel Syndrome (IBS) Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Irritable Bowel Syndrome (IBS) Market Concentration, in 2020
Figure Europe Irritable Bowel Syndrome (IBS) Market Market Concentration, in 2020
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) MMarket Concentration, in 2020
Figure South America Irritable Bowel Syndrome (IBS) Market Concentration, in 2020
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Market Concentration, in 2020

6 DEMAND BY END MARKET

6.1 Demand Situation
  6.1.1 Demand in Women
Figure Irritable Bowel Syndrome (IBS) Demand in Women, 2016-2020, in USD Million
Figure Irritable Bowel Syndrome (IBS) Demand in Women, 2016-2020, in Volume
  6.1.2 Demand in Men
Figure Irritable Bowel Syndrome (IBS) Demand in Men, 2016-2020, in USD Million
Figure Irritable Bowel Syndrome (IBS) Demand in Men, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Irritable Bowel Syndrome (IBS) Demand Forecast 2021-2026, by Application, in USD Million
Figure Irritable Bowel Syndrome (IBS) Market Growth 2021-2026, by Application, in USD Million
Figure Irritable Bowel Syndrome (IBS) Market Share in 2026, by Application, in USD Million
Table Irritable Bowel Syndrome (IBS) Demand Forecast 2021-2026, by Application, in Volume
Table Irritable Bowel Syndrome (IBS) Market Growth 2021-2026, by Application, in Volume
Table Irritable Bowel Syndrome (IBS) Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand

7 REGION OPERATION

7.1 Regional Production
Table Irritable Bowel Syndrome (IBS) Production 2016-2020, by Region, in USD Million
Table Irritable Bowel Syndrome (IBS) Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Irritable Bowel Syndrome (IBS) Market 2016-2020, by Region, in USD Million
Table Global Irritable Bowel Syndrome (IBS) Market Share 2016-2020, by Region, in USD Million
Table Global Irritable Bowel Syndrome (IBS) Market 2016-2020, by Region, in Volume
Table Global Irritable Bowel Syndrome (IBS) Market Share 2016-2020, by Region, in Volume
7.3 by Region
  7.3.1 North America
    7.3.1.1 Overview
Figure North America Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in USD Million
Figure North America Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in Volume
    7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in USD Million
Table North America Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in Volume
  7.3.2 Europe
    7.3.2.1 Overview
Figure Europe Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in USD Million
Figure Europe Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in Volume
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in USD Million
Table Europe Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in Volume
  7.3.3 Asia-Pacific
    7.3.3.1 Overview
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in Volume
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in Volume
  7.3.4 South America
    7.3.4.1 Overview
Figure South America Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in USD Million
Figure South America Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in Volume
    7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in USD Million
Table South America Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in Volume
  7.3.5 Middle East & Africa
    7.3.5.1 Overview
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in Volume
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Irritable Bowel Syndrome (IBS) Market Forecast 2021-2026, by Region, in USD Million
Table Irritable Bowel Syndrome (IBS) Market Forecast 2021-2026, by Region, in Volume

8 MARKETING & PRICE

8.1 Price and Margin
  8.1.1 Price Trends
  8.1.2 Factors of Price Change
Table Price Factors List
  8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview

9 RESEARCH CONCLUSION
LIST OF TABLES
1. Table Upstream Segment of Irritable Bowel Syndrome (IBS)
2. Table Application Segment of Irritable Bowel Syndrome (IBS)
3. Table Global Irritable Bowel Syndrome (IBS) Market 2016-2026, by Application, in USD Million
4. Table Major Company List of IBS-C Drug
5. Table Major Company List of Others
6. Table Global Irritable Bowel Syndrome (IBS) Market 2016-2020, by Type, in USD Million
7. Table Global Irritable Bowel Syndrome (IBS) Market 2016-2020, by Type, in Volume
8. Table Global Irritable Bowel Syndrome (IBS) Market Forecast 2021-2026, by Type, in USD Million
9. Table Global Irritable Bowel Syndrome (IBS) Market Forecast 2021-2026, by Type, in Volume
10. Table Valeant Pharmaceuticals Overview List
11. Table Business Operation of Valeant Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
12. Table Allergan Overview List
13. Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Takeda Overview List
15. Table Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Sucampo Pharmaceuticals Overview List
17. Table Business Operation of Sucampo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table McNeil Consumer Healthcare Overview List
19. Table Business Operation of McNeil Consumer Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Sebela Pharmaceuticals Overview List
21. Table Business Operation of Sebela Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Astellas Pharmaceuticals Overview List
23. Table Business Operation of Astellas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table IM HealthScience Overview List
25. Table Business Operation of IM HealthScience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Global Irritable Bowel Syndrome (IBS) Sales Revenue 2016-2020, by Company, in USD Million
27. Table Global Irritable Bowel Syndrome (IBS) Sales Revenue Share 2016-2020, by Company, in USD Million
28. Table Global Irritable Bowel Syndrome (IBS) Sales Volume 2016-2020, by Company, in Volume
29. Table Global Irritable Bowel Syndrome (IBS) Sales Volume Share 2016-2020, by Company, in Volume
30. Table Regional Demand Comparison List
31. Table Major Application in Different Regions
32. Table Irritable Bowel Syndrome (IBS) Demand Forecast 2021-2026, by Application, in USD Million
33. Table Irritable Bowel Syndrome (IBS) Demand Forecast 2021-2026, by Application, in Volume
34. Table Irritable Bowel Syndrome (IBS) Market Growth 2021-2026, by Application, in Volume
35. Table Irritable Bowel Syndrome (IBS) Market Share in 2026, by Application, in Volume
36. Table Irritable Bowel Syndrome (IBS) Production 2016-2020, by Region, in USD Million
37. Table Irritable Bowel Syndrome (IBS) Production 2016-2020, by Region, in Volume
38. Table Global Irritable Bowel Syndrome (IBS) Market 2016-2020, by Region, in USD Million
39. Table Global Irritable Bowel Syndrome (IBS) Market Share 2016-2020, by Region, in USD Million
40. Table Global Irritable Bowel Syndrome (IBS) Market 2016-2020, by Region, in Volume
41. Table Global Irritable Bowel Syndrome (IBS) Market Share 2016-2020, by Region, in Volume
42. Table North America Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in USD Million
43. Table North America Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in Volume
44. Table Europe Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in USD Million
45. Table Europe Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in Volume
46. Table Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in USD Million
47. Table Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in Volume
48. Table South America Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in USD Million
49. Table South America Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in Volume
50. Table Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in USD Million
51. Table Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size 2016-2020, by Country, in Volume
52. Table Irritable Bowel Syndrome (IBS) Market Forecast 2021-2026, by Region, in USD Million
53. Table Irritable Bowel Syndrome (IBS) Market Forecast 2021-2026, by Region, in Volume
54. Table Price Factors List
LIST OF FIGURES
1. Figure Irritable Bowel Syndrome (IBS) Industry Chain Structure
2. Figure Global Irritable Bowel Syndrome (IBS) Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Irritable Bowel Syndrome (IBS) Market Growth 2016-2020, by Type, in Volume
4. Figure Global Irritable Bowel Syndrome (IBS) Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Irritable Bowel Syndrome (IBS) Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Irritable Bowel Syndrome (IBS) Market Concentration, in 2020
7. Figure Europe Irritable Bowel Syndrome (IBS) Market Market Concentration, in 2020
8. Figure Asia-Pacific Irritable Bowel Syndrome (IBS) MMarket Concentration, in 2020
9. Figure South America Irritable Bowel Syndrome (IBS) Market Concentration, in 2020
10. Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Market Concentration, in 2020
11. Figure Irritable Bowel Syndrome (IBS) Demand in Women, 2016-2020, in USD Million
12. Figure Irritable Bowel Syndrome (IBS) Demand in Women, 2016-2020, in Volume
13. Figure Irritable Bowel Syndrome (IBS) Demand in Men, 2016-2020, in USD Million
14. Figure Irritable Bowel Syndrome (IBS) Demand in Men, 2016-2020, in Volume
15. Figure Irritable Bowel Syndrome (IBS) Market Growth 2021-2026, by Application, in USD Million
16. Figure Irritable Bowel Syndrome (IBS) Market Share in 2026, by Application, in USD Million
17. Figure North America Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in USD Million
18. Figure North America Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in Volume
19. Figure Europe Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in USD Million
20. Figure Europe Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in Volume
21. Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in USD Million
22. Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in Volume
23. Figure South America Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in USD Million
24. Figure South America Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in Volume
25. Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in USD Million
26. Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size and Growth 2016-2020, in Volume
27. Figure Marketing Channels Overview


More Publications